GlassScriptPhysician profile
Mireille Saint Juste
NPI 1093149403
$2,931.94
in general payments reported to CMS, 2019-2025
19 companies · $693 in 2025
The $693 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $421 · 2022: $837 · 2023: $633 · 2024: $349 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,319.69 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $510.98 | 2022-2025 | Tezspire, Breztri, Symbicort |
| Novo Nordisk INC | $311.44 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $163.70 | 2021-2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $120.36 | 2021-2023 | Verquvo, Steglatro, Belsomra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.26 | 2025 | Xifaxan |
| Abbvie INC. | $76.44 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $49.15 | 2023-2025 | Uptravi, Opsumit |
| Scilex Pharmaceuticals INC. | $48.26 | 2025 | |
| Mylan Specialty L.P. | $46.56 | 2022 | |
| Forte Bio-Pharma LLC | $40.91 | 2021 | |
| Evoke Pharma, INC. | $25.29 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.76 | 2022 | |
| Verona Pharma, INC. | $21.08 | 2025 | Ohtuvayre |
| Xeris Pharmaceuticals, INC. | $17.01 | 2023 | Gvoke Hypopen |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $15.82 | 2024 | Ibsrela |
| Amarin Pharma, INC. | $14.99 | 2021 | |
| Hikma Pharmaceuticals USA | $14.05 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mireille Saint Juste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.